KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Raw Materials (2016 - 2022)

Historic Raw Materials for Bio-Rad Laboratories (BIO) over the last 14 years, with Q2 2022 value amounting to $188.5 million.

  • Bio-Rad Laboratories' Raw Materials rose 5687.29% to $188.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $188.5 million, marking a year-over-year increase of 5687.29%. This contributed to the annual value of $116.9 million for FY2021, which is 790.4% down from last year.
  • Per Bio-Rad Laboratories' latest filing, its Raw Materials stood at $188.5 million for Q2 2022, which was up 5687.29% from $146.2 million recorded in Q1 2022.
  • In the past 5 years, Bio-Rad Laboratories' Raw Materials ranged from a high of $188.5 million in Q2 2022 and a low of $104.0 million during Q1 2020
  • In the last 5 years, Bio-Rad Laboratories' Raw Materials had a median value of $118.3 million in 2018 and averaged $123.3 million.
  • Per our database at Business Quant, Bio-Rad Laboratories' Raw Materials plummeted by 1841.31% in 2021 and then surged by 5687.29% in 2022.
  • Bio-Rad Laboratories' Raw Materials (Quarter) stood at $108.0 million in 2018, then increased by 1.45% to $109.6 million in 2019, then rose by 15.83% to $126.9 million in 2020, then fell by 7.9% to $116.9 million in 2021, then surged by 61.26% to $188.5 million in 2022.
  • Its last three reported values are $188.5 million in Q2 2022, $146.2 million for Q1 2022, and $116.9 million during Q4 2021.